Non-adjuvant chemotherapy of bladder neoplasms stage T3-4 using NO-x and MO. Preliminary results of the urogenital study group of the European Organization for Research and Treatment of Cancer
Bollack, C.; Jacqmin, D.; Splinter, T.A.; De Pauw, M.
Casopis Lekaru Ceskych 127(35): 1098-1100
1988
ISSN/ISBN: 0008-7335 PMID: 3197062 Document Number: 307259
Document emailed within 1 workday
Related Documents
Wagener, D.J.; van Oosterom, A.T.; Mulder, J.H.; Somers, R.; Mouridsen, H.T.; Cortes Funes, H.; Thomas, D.; Sylvester, R. 1986: Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer Cancer Treatment Reports 70(5): 615-618Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Van Zandwijk, N.; Dalesio, O. 1994: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer Seminars in Oncology 21(3 Suppl 6: 66-71
Smith, P.H.; de Pauw, M.; Sylvester, R. 1984: The urological group of the EORTC (European Organization for Research on the Treatment of Cancer), 1976-1984 Archivos Espanoles de Urologia 37 Suppl. 2: 713-723
Bidziński, M.; Danska-Bidzińska, A.; Ziółkowska-Seta, I.; Derlatka, P.; Sobiczewski, P.; Raczyński, P. 2005: Analysis of the treatment of ovarian cancer patients with neo-adjuvant chemotherapy--preliminary results European Journal of Gynaecological Oncology 26(4): 423-426
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456
Metzger, U.; Laffer, U.; Egeli, R.; Barras, J.; Martinoli, S.; Müller, W.; Arma, S.; Bär, H.U.; Schweizer, W.; Aeberhard, P. 1989: Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81) Helvetica Chirurgica Acta 56(4): 455-460
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Sirisinha, T.; Ratanatharathorn, V.; Jirajarus, M.; Sirilerttrakul, S.; Silpakit, C.; Sirachainan, E.; Tanvetyanon, T. 2002: The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version Journal of the Medical Association of Thailand 85(11): 1210-1219
Buesa, J.M.; Mouridsen, H.T.; Santoro, A.; Somers, R.; Bramwell, V.; van Oosterom, A.T.; Wagener, T.; Vendrik, C.; Thomas, D. 1984: Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase Ii trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Cancer Treatment Reports 68(4): 683-684
Trifard, F.; Chrétien, Y.; Vallantin, X.; Collet, C.; Lachand, A.T.; Dufour, B. 1988: [Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients Annales d'Urologie 22(3): 216-219
Dede, M.; Yenen, M.C.; Goktolga, U.; Duru, N.K.; Guden, M.; Dilek, S.; Pabuccu, R. 2004: Is adjuvant therapy necessary for peritoneal cytology-positive surgical-pathologic Stage I endometrial cancer? Preliminary results European Journal of Gynaecological Oncology 25(5): 591-593
1997: Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK) European Journal of Surgery 163(9): 693-701
Tomizawa, K.; Hanaoka, Y.; Toda, S.; Moriyama, J.; Matoba, S.; Kuroyanagi, H.; Hashimoto, M.; Udagawa, H.; Watanabe, G. 2013: A retrospective study of UFT and oral leucovorin combination adjuvant chemotherapy for patients over 76 years old with stage III colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 881-885
Martinez-Piñeiro, J.A.; Jimenez Leon, J.; Gonzalez Martin, M.; Arocena Lanz, F.; Ramos Roncero, C.; Flores, N.; Portillo, J.A.; Escudero, A.; Jimenez Cruz, F.; Isorna, S. 1990: Neo-adjuvant cisplatinum in locally advanced urothelial bladder cancer: a prospective randomized study of the group CUETO Progress in Clinical and Biological Research 353: 95-103
Sato, Y.; Yajima, K.; Kosugi, S-ichi.; Muneoka, Y.; Ichikawa, H.; Hanyu, T.; Sakamoto, K.; Ishikawa, T.; Wakai, T. 2014: Current status of adjuvant chemotherapy in patients with p-Stage II and p-Stage III gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(8): 961-964
Nakazato, H.; Ichihashi, H.; Kondo, T. 1986: Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(2): 308-318
Cigolari, S.; Curcio, C.; Maiorino, A.; Sessa, R.; Cioffi, A.; Massimo, M. 2003: Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study Anticancer Research 23(2c): 1803-1809
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Skarlos, D.V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G.P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G. 1997: Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study Seminars in Oncology 24(5 Suppl 15: S15